 |
GreetingsHaving been active in the Biotech sector since 1985, I am sure that many of you will agree with me that 2009 will go down as one of the most challenging years in the sector. So as the holiday festivities approach, I hope that you will be able to take some time out to relax and to look forward to a more prosperous year in 2010. |
 |
The signs in the last few months are very positive with activity around new funds, financings, transactions, launches and new deals. November and December have been very busy for us and, as the New year fast approaches, January looks to continue that trend. Time will tell if 2009 has changed the "model" forever - or whether it has been just another step in the evolution of the ever changing life sciences ecosystem. All companies have had to learn to live with tighter and more focused budgets, and more flexible operations. The fittest have emerged and will no doubt grow forward stronger. Good luck to you all! In this issue of our newsletter we look at some of our more active projects from recent months and include our article just published in Nature Bioentrepreneur that explores how investment in branding can pay dividends. We are planning an active conference schedule in 2010 so we hope to meet you at one of these events.
Season's Greetings and a Happy New Year
from the entire College Hill Life Sciences team.
Sue Charles
Managing Partner, Life Sciences
|
Features
College Hill announces PanGenetics deal with Abbott
College Hill's life sciences team has a long standing relationship with the Dutch biotech company PanGenetics BV, so when the company closed a deal with pharmaceutical giant, Abbott, to sell its anti-NGF antibody PG 110 for over $190 million (of which $170 million upfront), it asked College Hill to support its media outreach in the Dutch and UK financial and biotech trade press. The deal attracted a lot of attention with excellent and widespread coverage.
View News Item
|
A new visual identity and website
for Telormedix
Having been a client for just over a year, when Telormedix underwent a management change in October, College Hill Life Sciences was tasked with transforming its website and visual identity. A clinical stage biopharmaceutical company focussed on targeted immunity, Telormedix wanted a visual change to reflect the Company's growth.
View News Item
View Telormedix Website
|
In Press
Nature Biotechnology - Bioentrepreneur
Managing Partner, Sue Charles, and Creative Director, Chris Fisher, were commissioned to submit an article aimed at helping biotechs understand how branding can contribute to their businesses. Read the article, "Backing your Brand" online. It will be in the publication's January print issue.
Read the full article
|
In Brief
New Biz: In recent months, College Hill Life Sciences has started working with a number of new clients including: Accentus Medical, Amarantus (formerly CNS Protein Therapeutics), Bioceramic Therapeutics, HBM Ventures, Karus Therapeutics, Medical Device Works, SeQual Technologies, Scil Proteins, Telormedix, Therium Capital, Vivostat and 2B Scientific.
Jane Goodall Institute: Managing Partner, Sue Charles is now a trustee of the Jane Goodall Institute UK. To find out more or to support JGI's work to ensure the conservation of endangered chimpanzees, click here.
US Update: Having only opened its doors in January of this year, the College Hill Life Sciences San Francisco Team has gone from strength to strength with a number of high profile new business wins. Read More…
|
Events We Are Supporting
Sachs Biotech In Europe Investor and Partnering Forum
11 - 12 February 2010
Zurich, Switzerland
Medtech Investing Europe
18 - 19 February 2010
Lausanne, Switzerland
MedTech Investing Europe
29 - 30 April 2010
Paris, France
Sachs Biotech in Europe Investor Forum
27 - 28 September, 2010
Zurich, Switzerland
|
|
News
Increasing Importance
of Communications
Two surveys recently conducted by College Hill Life Sciences have found that, despite the global economic recession, nearly two-thirds of Life Science companies either plan to increase or maintain their spend on strategic external communications in the coming year, with a growing reliance on new communications channels. More…
|
GE Healthymagination
Having had long standing relationships with GE Healthcare's corporate PR and life sciences marketing communications teams, when GE prepared to announce the launch of a $250 Million venture fund and wanted to ensure coverage in healthcare, life sciences and financial media it came to College Hill for support. Using a wide network of contacts, College Hill worked with GE to secure coverage in the relevant media. More…
|
Exploring investment models
Index Ventures Forum, Rome
Managing Partner, Sue Charles reports from this year's Index Ventures, Forum - an annual gathering in Italy of the firm's portfolio companies with industry advisors and senior pharma executives. This year's theme included models for investing in the new financial landscape, including Index's asset-centric approach.
More…
|
BioInvent
Congratulations to our client BioInvent who won "Licensing Deal of the Year" at this year's Scrip Awards. This highly contested accolade was awarded in recognition of the major partnership deal that BioInvent and ThromboGenics signed with Roche for their novel anti-cancer monoclonal antibody TB-403 (anti-PIGF). Under the terms of the deal, BioInvent and ThromboGenics received €50 million upfront with the potential for an additional €450million, as well as royalties on future product sales. More…
|
DxS Aquired by Qiagen
Having built DxS' profile over the last 15 months, as a leading player in the companion diagnostics field, College Hill Life Sciences was delighted to support the Company's announcement of its acquisition by leading global provider of sample and assay technologies, Qiagen.
Read more about our work for DxS…
|
Executive coaching sharpens
your skills
College Hill has a dedicated team offering presentation coaching and media coaching to senior executives ahead of critical presentations and interviews. Coaching can range from a few hours to ongoing development. In the words of a recent Coaching client "Your training was extremely helpful. It made us think about our story in new ways. Also seeing ourselves on video was enlightening. The props (your suggestion) were a big hit - caused a few laughs at the beginning of the meeting as well as being used a couple of times during. We would definitely come back to you for this kind of thing." If you would like to find out more click here or gives us a call to discuss your needs in confidence. Read our Coaching Booklet…
|
|
Meet Us At
11 - 14 Jan
JP Morgan 28th Annual Healthcare Conference
San Francisco, USA - Erik Clausen
19 - 20 Jan
BioBusiness
London, UK - Sue Charles
28 Jan
BIA Gala Dinner
London, UK - Sue Charles
1 - 2 Feb
BioSquare 2010
Genenva, Switzerland - Katja Stout
3 - 5 Feb
17th Annual Molecular Medicine Tri-Conference
San Francisco, USA - Erik Clausen
8 - 9 Feb
BIO CEO & Investor Conference
New York City, USA - Erik Clausen
11 - 12 Feb
Sachs Biotech in Europe Investor and Partnering Forum
Zurich, Switzerland - Dr Douglas Pretsell
18 - 19 Feb
MedTech Investing Europe
Lausanne, Switzerland - Dr Douglas Pretsell
25 - 26 Feb
Biomarkers congress
Manchester, UK - Lorna Cuddon
|
8 - 10 Mar
BioEurope Spring
Barcelona, Spain - Katja Stout
14 - 16 Mar
ACC 2010
Atlanta, USA - Erik Clausen
23 - 26 Mar
Analytica
Munich, Germany - Dr Douglas Pretsell and Dr Lynne Trowbridge
25 Mar
BioFinance and BioInnovate Europe 2010
London, UK - Sue Charles
30 - 31 Mar
Peptide Conference 2010
Cambridge, UK - Lorna Cuddon
17 Mar
BayBio 2010
San Francisco, USA - Erik Clausen
6 - 7 Apr
BIONational Venture Conference
Boston, USA - Erik Clausen
22 - 23 Apr
Drug Development Congress
London, UK - Dr Lynne Trowbridge
29 - 30 Apr
MedTech Investing Europe
Paris, France - Dr Douglas Pretsell
|
29 Apr
BioCapital 2010
Amsterdam, Holland - Sue Charles
3 - 6 May
BIO 2010
Chicago, USA - Erik Clausen
19 - 20 May
BioEquity
Amsterdam, Holland - Dr Douglas Pretsell
1 - 2 Jun
Euro MedTech
Leipzig, Germany - Dr Douglas Pretsell
2 - 4 Jun
ERBI BioPartnering Exchange
Cambridge, UK - Lorna Cuddon
21 - 23 Jun
Barcelona Vaccine Forum
Barcelona, Spain - Dr Marc Egelhofer
23 Jun
EPIC 7 (European Partnering and Investment Conference)
London, UK - Sue Charles
24 Jun
European Mediscience Awards Dinner
London, UK - Sue Charles & Katja Stout
|
|
|
London Tel: +44 (0)20 7457 2020 Manchester Tel: +44 (0)1260 296 500 Munich Tel: +49 (0)89 5700 1806 San Francisco Tel: +1 (415) 230 5385
|
|
www.collegehill-lifesciences.com
|
College Group – News
|
College Hill to Advise Caledonia on European Directive
College Hill will be providing public affairs and media support to Caledonia Investments over plans being proposed by the European Commission to impose tighter restrictions on private equity and hedge funds. College Public Policy will be providing public affairs support to highlight issues the proposed Alternative Investment Fund Managers' Directive creates for Caledonia.
Read this press release…
Mike Davies Joins College Hill
Mike Davies, formally Corporate and Financial senior Director at Bell Pottinger, has joined College Hill's Industrial team. Mike advised clients across a wide range of sectors during his three years at Bell Pottinger and will provide expertise to a number of teams at College Hill.
Read this press release…
|
College Hill to Provide Strategic Corporate Communications Advice to English National Opera
Amid stiff competition, College Hill has been appointed to advise the English National Opera on corporate media relations and expand on a hugely successful 2008/09 season. James Hogan, who leads the international media sector practice, will provide strategic advice for the forthcoming 2009/10 Season. Read this press release…
College Hill Adds Brussels to Public Affairs Practice
College Hill announces that it has invested in Policy Action, a leading Public Affairs Consultancy in Brussels that is renowned for enhancing its clients at EU level. Policy action was founded 10 years ago and has built a high quality client base across a range of industry sectors. Policy Action joins rapidly growing College Public Policy, led by its managing partner Warwick Smith. Read this press release…
|
|
College Group – Insight
 College Public Policy is a leader in the field of Public Affairs and Government relations. Over the past year, CPP has grown to include Communique and Green Issues, extending their specialist teams to cover local authorities and planning assistance. CPP works alongside its sister companies under the College Group umbrella, mixing a top flight research capability with political instinct and experience to deliver a full range of government relations and public affairs provisions. Under the broad heading of "Public Affairs", the team promotes positive engagement with the institutions of government through specialist services including; regulatory advice, reputation management, select committee support and training; strategic political counsel; and trade policy.
Amongst the team are some of the biggest names in the UK public policy arena, heralding national acclaim. In October 2009, Total Politics Magazine named Managing Partner Warwick Smith no.1 in its list of Top 100 Public Affairs professionals, while Partner Robbie MacDuff was placed 9th. More…
|
|
|
